Medicure (FRA:NGQ1) E10: €-0.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NGQ1 Medicure Inc FRA:NGQ1
63 GF Score
Price €1.52
GF Value €0.94
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Medicure E10?

Medicure FRA:NGQ1 -0.65% 63 E10 is €-0.11 as of Jun. 2026. GuruFocus rates FRA:NGQ1 with a GF Score™ of 63/100 and a GF Value™ of €0.94 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medicure's adjusted earnings per share data for the three months ended in Jun. 2026 was €-0.085. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.11 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medicure's average E10 Growth Rate was -28.60% per year. During the past 3 years, the average E10 Growth Rate was -5.40% per year. During the past 5 years, the average E10 Growth Rate was -8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Medicure was 54.50% per year. The lowest was -21.20% per year. And the median was 1.95% per year.

As of today (2026-09-15), Medicure's current stock price is €1.52. Medicure's E10 for the quarter that ended in Jun. 2026 was €-0.11. Medicure's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Medicure was 125.67. The lowest was 1.52. And the median was 4.32.


Medicure  (FRA:NGQ1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Medicure was 125.67. The lowest was 1.52. And the median was 4.32.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medicure E10 Related Terms


Medicure E10 Historical Data

* Premium members only.

The historical data trend for Medicure's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicure E10 Chart

Medicure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.04 -0.06 -0.12

Medicure Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.05 -0.09 -0.09 -0.11

FRA:NGQ1 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicure Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medicure's Shiller PE Ratio falls into.


FRA:NGQ1
63GF Score
Medicure Inc FRA:NGQ1
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicure E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medicure's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.085/133.5265*133.5265
=-0.085

Current CPI (Jun. 2026) = 133.5265.

Medicure Quarterly Data

per share eps CPI Adj_EPS
201609 0.082 101.765 0.108
201612 0.973 101.449 1.281
201703 -0.234 102.634 -0.304
201706 0.061 103.029 0.079
201709 0.068 103.345 0.088
201712 -0.162 103.345 -0.209
201803 0.052 105.004 0.065
201806 0.059 105.557 0.074
201809 -0.023 105.636 -0.029
201812 0.065 105.399 0.082
201903 -0.118 106.979 -0.147
201906 -0.042 107.690 -0.051
201909 -0.027 107.611 -0.034
201912 -0.739 107.769 -0.916
202003 -0.091 107.927 -0.113
202006 0.001 108.401 0.001
202009 -0.063 108.164 -0.078
202012 -0.263 108.559 -0.323
202103 -0.067 110.298 -0.081
202106 -0.042 111.720 -0.050
202109 -0.062 112.905 -0.073
202112 0.129 113.774 0.152
202203 0.033 117.646 0.037
202206 -0.049 120.806 -0.054
202209 0.081 120.648 0.090
202212 0.032 120.964 0.035
202303 0.019 122.702 0.021
202306 0.017 124.203 0.018
202309 0.005 125.230 0.005
202312 -0.101 125.072 -0.108
202403 0.003 126.258 0.003
202406 -0.079 127.522 -0.083
202409 0.044 127.285 0.046
202412 -0.036 127.364 -0.037
202503 -0.044 129.181 -0.045
202506 -0.048 129.892 -0.049
202509 -0.083 130.287 -0.085
202512 -0.249 130.366 -0.255
202603 -0.024 132.262 -0.024
202606 -0.085 133.527 -0.085

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.11 mean?
Medicure (FRA:NGQ1) has a E10 of €-0.11 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medicure and its competitors.
Is Medicure's E10 too high?
Medicure's current E10 is €-0.11. Overall, Medicure has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medicure's E10 compare to ZTS?
Medicure's E10 of €-0.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medicure and its competitors. Medicure's current E10 is €-0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicure stock overvalued right now?
Based on GuruFocus' analysis, Medicure (FRA:NGQ1) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.94, compared to a current price of €1.52 — trading 61.7% above its estimated fair value. The current E10 is €-0.11. Medicure's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Medicure (FRA:NGQ1), the current E10 is €-0.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicure (FRA:NGQ1) Overvalued in 2026?

Based on GuruFocus' analysis, Medicure stock appears to be overvalued. The current stock price of €1.52 is trading 61.7% above its estimated GF Value™ of €0.94. GuruFocus considers Medicure to be Significantly Overvalued.

Key valuation signals for FRA:NGQ1:

  • E10: €-0.11
  • GF Value™: €0.94 vs. price of €1.52 (61.7% above fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the FRA:NGQ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicure Business Description

Other Exchanges MCUJF:USAMPH:Canada
Address 1250 Waverley Street, No. 2, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.
63GF Score

Get the complete analysis for FRA:NGQ1

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.52
Price
€0.94
GF Value